DEA Reverses Decision on Kratom Pending Further Investigation of the Plant
The Drug Enforcement Administration (DEA) is walking back its August decision to classify kratom as a Schedule I drug. Kratom is a plant native to Southeast Asia that has been used since at least the nineteenth century to treat chronic …